InvestorsHub Logo
Followers 4
Posts 1242
Boards Moderated 0
Alias Born 01/16/2016

Re: Money maker 110 post# 2883

Tuesday, 01/24/2017 9:38:58 AM

Tuesday, January 24, 2017 9:38:58 AM

Post# of 6602
http://ir.eksobionics.com/press-releases/detail/598/national-institute-for-health-and-care-excellence-releases

The MIB authors conducted a systematic review of existing evidence on multiple patient groups and noted that, while the evidence base was still limited, results indicated enhancement in walking speed and distance for patients who use the Ekso GT as a rehabilitation tool. British specialist commentators who have used the device noted in the MIB that Ekso GT helps patients with incomplete spinal cord injuries improve mobility more quickly by providing a means for repetitive controlled practice and also noted that the capability for Ekso’s SmartAssist software to apply different power to each leg might be particularly useful for stroke patients. The MIB also points out that there were psychological benefits associated with users being able to stand and walk, which in turn could have a positive effect on their overall health.

“The NHS in the United Kingdom is highly respected and is looked upon as a reference by many neighboring countries. We are honored that NICE chose the Ekso GT as the first exoskeleton to be the subject of a Medtech Innovation Briefing,” stated Thomas Looby, chief executive officer of Ekso Bionics. “We are thrilled with the findings and the support of the MIB and are optimistic about the impact it can have on the momentum for Ekso Bionics in Europe.”

The MIB report can be found at: https://www.nice.org.uk/advice/mib93.


---
I hold EKSO long
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EKSO News